Call for Papers  

Article Details


Corrigendum

Corrigendum to: Mechanism of HSP90 Inhibitor in the Treatment of DSS-induced Colitis in Mice by Inhibiting MAPK Pathway and Synergistic Effect of Compound Sophorae Decoction

[ Vol. 30 , Issue. 17 ]

Author(s):

Yuyi Yuan, Hui Wu, Bo Shuai, Chang Liu, Feng Zhu, Fei Gao, Chunzhu Wei and Heng Fan*   Pages 1377 - 1377 ( 1 )

Abstract:


A typographical error appeared in the title of the article “Mechanism of HSP90 Inhibitor in the Treatment of DSS-induced Colitis in Mice by Inhibiting MAPK Pathway and Synergistic Effect of Compound Sophora Decoction”, published in Current Pharmaceutical Design, 2022; 28(42): 3456-3468 [1].

Details of the error and a correction are provided below.

Original:

Mechanism of HSP90 Inhibitor in the Treatment of DSS-induced Colitis in Mice by Inhibiting MAPK Pathway and Synergistic Effect of Compound Sophora Decoction

Corrected:

Mechanism of HSP90 Inhibitor in the Treatment of DSS-induced Colitis in Mice by Inhibiting MAPK Pathway and Synergistic Effect of Compound Sophorae Decoction

We regret the error and apologize to readers.

The original article can be found online at: https://www.eurekaselect.com/article/127740

Keywords:

Affiliation:



Read Full-Text article